| Name | Title | Contact Details |
|---|
The West Virginia Health Information Network (WVHIN) offers services that enable the secure electronic exchange of patient health information, providing benefits to health care providers, health care systems and patients. In February 2010, the West Virginia Department of Health and Human Resources received $7.8 million in federal funds as part of the State Health Information Exchange Cooperative Agreement Program. The West Virginia Health Information Network (WVHIN) is using these funds to launch WVHIN’s statewide electronic health information exchange services. In August 2011, the WVHIN chose Truven Health Analytics as its technical services partner. Together with Truven Health and its strategic partners, the WVHIN has made the electronic exchange of patient health information a reality for health care providers and patients across the State of West Virginia.
Ritter Pharmaceuticals, Inc. is a specialty pharmaceutical company developing therapeutics based upon colonic adaptation to treat gastrointestinal diseases with an initial focus on lactose intolerance. Colonic adaptation improves colon function by selectively increasing the growth of beneficial bacteria in the colonic ecosystem (digestive tract). Ritter Pharmaceuticals, Inc. is rapidly establishing itself as the world`s leader in lactose intolerance research based upon its scientific team and their cutting edge research in this field. RP-G28, Ritter`s lead product, has been studied in a Phase 2 trial and is a first-in-class compound. RP-G28 has the potential to become the first FDA-approved drug for the treatment of lactose intolerance, a debilitating disease which affects over 1 billion people worldwide.
Regenstrief Institute, Inc., an international leader in electronic medical records and health care data integration, is a medical research and development organization focused on improving quality of care, efficiency of health care delivery, and enhancing patient outcomes.
ConnectYourCare’s comprehensive and flexible consumer-directed health care (CDH) solution provides a fast path to account-based health plans like Health Savings Accounts (HSA), Flexible Spending Accounts (FSA), Health Reimbursement Arrangements (HRA) and other tax-advantaged benefit accounts including COBRA, Transportation and Adoption Assistance. We help businesses lower benefit costs while empowering consumers to achieve health care savings with simple, powerful tools and a robust suite of educational materials. The solution of choice for brokers, employers, health plans and banks, ConnectYourCare’s smartCDH™ technology platform offers a fresh approach to health savings by combining a simplified experience and seamless access. Developed with all tax-advantaged savings accounts in mind, smartCDH works with equal precision across all account types – and those still to come. By removing complexity and motivating individuals to take control of health savings, ConnectYourCare maximizes return on investment for all participants in the health care benefits marketplace.
New York Proton Center is creating the gold standard for proton therapy, giving new hope to patients living with cancer. In partnership with leading academic medical centers—Memorial Sloan Kettering Cancer Center, Montefiore Health System, Mount Sinai Health System, and ProHEALTH as manager—New York Proton Center brings together expert oncologists, clinical care teams, and researchers to improve cancer care and advance the clinical evidence for proton therapy.